ST7
Suppressor of tumorigenicity 7 protein
Also known as: ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, ST7_HUMAN, TSG7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRC1
- Gene
- ST7
- Ensembl
- ENSG00000004866
- Chromosome
- 7
- Canonical length
- 585 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The gene for this product maps to a region on chromosome 7 identified as an autism-susceptibility locus. Mutation screening of the entire coding region in autistic individuals failed to identify phenotype-specific variants, suggesting that coding mutations for this gene are unlikely to be involved in the etiology of autism. The function of this gene product has not been determined. Transcript variants encoding different isoforms of this protein have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
585 residues, UniProt reviewed canonical sequence.
>Q9NRC1|ST7
1 MAEAATGFLE QLKSCIVWSW TYLWTVWFFI VLFLVYILRV PLKINDNLST VSMFLNTLTP
61 KFYVALTGTS SLISGLILIF EWWYFRKYGT SFIEQVSVSH LRPLLGGVDN NSSNNSNSSN
121 GDSDSNRQSV SECKVWRNPL NLFRGAEYNR YTWVTGREPL TYYDMNLSAQ DHQTFFTCDS
181 DHLRPADAIM QKAWRERNPQ ARISAAHEAL EINEIRSRVE VPLIASSTIW EIKLLPKCAT
241 AYILLAEEEA TTIAEAEKLF KQALKAGDGC YRRSQQLQHH GSQYEAQHRR DTNVLVYIKR
301 RLAMCARRLG RTREAVKMMR DLMKEFPLLS MFNIHENLLE ALLELQAYAD VQAVLAKYDD
361 ISLPKSATIC YTAALLKARA VSDKFSPEAA SRRGLSTAEM NAVEAIHRAV EFNPHVPKYL
421 LEMKSLILPP EHILKRGDSE AIAYAFFHLA HWKRVEGALN LLHCTWEGTF RMIPYPLEKG
481 HLFYPYPICT ETADRELLPS FHEVSVYPKK ELPFFILFTA GLCSFTAMLA LLTHQFPELM
541 GVFAKAMIDI FCSAEFRDWN CKSIFMRVED ELEIPPAPQS QHFQNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ST7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- liver: 39 nTPM
- epididymis: 34 nTPM
- pancreas: 31 nTPM
- cerebellum: 29 nTPM
- kidney: 27 nTPM
- thyroid gland: 27 nTPM
Single-cell type
- proximal tubule cells: 356 nCPM
- renal collecting duct intercalated cells: 301 nCPM
- renal connecting tubule cells: 209 nCPM
- early spermatids: 182 nCPM
- renal collecting duct principal cells: 158 nCPM
- loop of henle epithelial cells: 143 nCPM
Immune cell
- T-reg: 10 nTPM
- gdT-cell: 7.3 nTPM
- NK-cell: 7.1 nTPM
- memory CD8 T-cell: 6.2 nTPM
- myeloid DC: 5.7 nTPM
- plasmacytoid DC: 5.6 nTPM
Brain region
- cerebellum: 102 nTPM
- hypothalamus: 45 nTPM
- cerebral cortex: 44 nTPM
- basal ganglia: 44 nTPM
- hippocampal formation: 40 nTPM
- white matter: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ST7.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 62 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.26
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.38
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ST7 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ST7 as an antibody target. Whether an autoantibody or antibody against ST7 could matter depends on whether native ST7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ST7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ST7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...